Kailera Therapeutics, Inc. (KLRA) KPIs and segments
KLRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$12.20−0.37 (-2.94%)
Close on Nov 17, 2026Market cap $1.58BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Kailera Therapeutics's business
Coming soon
This tab will track the numbers specific to Kailera Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?